329 related articles for article (PubMed ID: 29313215)
61. Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients.
Chan A; Yo TE; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
J Pain Symptom Manage; 2018 Mar; 55(3):992-997.e2. PubMed ID: 29097274
[TBL] [Abstract][Full Text] [Related]
62. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
63. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer.
Andrykowski MA; Schmidt JE; Salsman JM; Beacham AO; Jacobsen PB
J Clin Oncol; 2005 Sep; 23(27):6613-22. PubMed ID: 16170168
[TBL] [Abstract][Full Text] [Related]
64. Neoadjuvant chemotherapy in patients with locally advanced breast cancer: A pilot-observational study.
Dodiya HG; Brahmbhatt AP; Khatri PK; Kaushal AM; Vijay DG
J Cancer Res Ther; 2015; 11(3):612-6. PubMed ID: 26458590
[TBL] [Abstract][Full Text] [Related]
65. Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.
Kim H; Park W; Yu JI; Choi DH; Huh SJ; Kim YJ; Lee ES; Lee KS; Kang HS; Park IH; Shin KH; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):970-980. PubMed ID: 28052649
[TBL] [Abstract][Full Text] [Related]
66. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.
Minisini AM; Menis J; Valent F; Andreetta C; Alessi B; Pascoletti G; Piga A; Fasola G; Puglisi F
Anticancer Drugs; 2009 Jul; 20(6):503-7. PubMed ID: 19339872
[TBL] [Abstract][Full Text] [Related]
67. Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.
Fernandes R; Mazzarello S; Joy AA; Pond GR; Hilton J; Ibrahim MFK; Canil C; Ong M; Stober C; Vandermeer L; Hutton B; da Costa M; Damaraju S; Clemons M
Support Care Cancer; 2018 Sep; 26(9):3073-3081. PubMed ID: 29564623
[TBL] [Abstract][Full Text] [Related]
68. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
[TBL] [Abstract][Full Text] [Related]
69. Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force.
Biganzoli L; Aapro M; Loibl S; Wildiers H; Brain E
Cancer Treat Rev; 2016 Feb; 43():19-26. PubMed ID: 26827689
[TBL] [Abstract][Full Text] [Related]
70. Comparison of three adjuvant chemotherapy regimes using an extended log-logistic model in women with operable breast cancer.
Faradmal J; Kazemnejad A; Khodabakhshi R; Gohari MR; Hajizadeh E
Asian Pac J Cancer Prev; 2010; 11(2):353-8. PubMed ID: 20843115
[TBL] [Abstract][Full Text] [Related]
71. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
Wielgus KK; Berger AM; Hertzog M
Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
[TBL] [Abstract][Full Text] [Related]
72. Correlation Between Mitochondrial DNA Content Measured in Myocardium and Peripheral Blood of Patients with Non-Ischemic Heart Failure.
Knez J; Lakota K; Božič N; Okrajšek R; Cauwenberghs N; Thijs L; Kneževič I; Vrtovec B; Tomšič M; Čučnik S; Sodin-Šemrl S; Kuznetsova T; Brguljan-Hitij J
Genet Test Mol Biomarkers; 2017 Dec; 21(12):736-741. PubMed ID: 29087733
[TBL] [Abstract][Full Text] [Related]
73. Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.
Zhang P; Sun T; Zhang Q; Yuan Z; Jiang Z; Wang XJ; Cui S; Teng Y; Hu XC; Yang J; Pan H; Tong Z; Li H; Yao Q; Wang Y; Yin Y; Sun P; Zheng H; Cheng J; Lu J; Zhang B; Geng C; Liu J; Peng R; Yan M; Zhang S; Huang J; Tang L; Qiu R; Xu B;
Lancet Oncol; 2017 Mar; 18(3):371-383. PubMed ID: 28209298
[TBL] [Abstract][Full Text] [Related]
74. A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.
Ibrahim EY; Munshani S; Domenicano I; Rodwin R; Nowak RJ; Pusztai L; Lustberg M; Ehrlich BE
PLoS One; 2022; 17(10):e0275648. PubMed ID: 36206298
[TBL] [Abstract][Full Text] [Related]
75. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
[TBL] [Abstract][Full Text] [Related]
76. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
77. Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.
Lambertini M; Bruzzi P; Poggio F; Pastorino S; Gardin G; Clavarezza M; Bighin C; Pronzato P; Del Mastro L
Support Care Cancer; 2016 Mar; 24(3):1285-94. PubMed ID: 26306520
[TBL] [Abstract][Full Text] [Related]
78. Tired of feeling tired - The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors.
Maurer T; Jaskulski S; Behrens S; Jung AY; Obi N; Johnson T; Becher H; Chang-Claude J
Breast; 2021 Apr; 56():103-109. PubMed ID: 33668004
[TBL] [Abstract][Full Text] [Related]
79. [Analysis of the factors affecting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients].
Sun B; Song ST; Jiang ZF; Wang T; Zhang SH; Meng XY; Li XB; Yu CZ; Wu SK
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):38-42. PubMed ID: 23648298
[TBL] [Abstract][Full Text] [Related]
80. Possible mechanisms behind taxane-anthracycline sequencing.
Sahin I; Ararat E; Altundag K
Lancet Oncol; 2010 Jun; 11(6):514-5. PubMed ID: 20522380
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
